← Back to Screener
Regentis Biomaterials Ltd. (RGNT)
Price$1.63
Momentum ScoreF
Favorite Metrics
Price vs S&P 500 (4W)-40.51%
VGM Score5.30
All Metrics
Price vs S&P 500 (YTD)-82.26%
10-Day Avg Trading Volume0.05M
3-Month Avg Trading Volume0.02M
52-Week High$8.35
13-Week Price Return-54.71%
3-Month Return Std Dev84.51%
Year-to-Date Return-72.55%
5-Day Price Return-16.29%
Month-to-Date Return-36.43%
Price vs S&P 500 (13W)-64.46%
52-Week Low$1.80
mGradeF
vgmGradeF
Show chart for
Industry Peers — Orthopedic & Prosthetic Devices(33)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
RGNTRegentis Biomaterials Ltd. | — | — | F | $1.63 |
| ISRGIntuitive Surgical Inc. | D | B | D | $412.26 |
| EWEdwards Lifesciences Corp | D | C | C | $88.16 |
| STESTERIS plc | C | B | D | $211.07 |
| ZBHZimmer Biomet Holdings, Inc. | B | C | D | $82.94 |
| ALGNAlign Technology Inc | C | C | C | $169.77 |
| SNNSmith & Nephew plc | B | C | C | $29.48 |
| MSAMine Safety Incorporated | C | C | C | $163.13 |
| ESTAEstablishment Labs Holdings Inc. | F | A | B | $68.08 |
| CDRECadre Holdings, Inc. | C | C | D | $30.62 |
| ENOVEnovis Corporation | B | D | D | $21.70 |
About
Regentis Biomaterials develops regenerative medicine solutions for orthopedic tissue repair. Its lead product, GelrinC, is a cell-free hydrogel implant designed to treat cartilage injuries in the knee, based on the company's proprietary Gelrin platform. The company targets the significant market opportunity in orthopedic regenerative medicine.